Celltrion
068270.KS
#844
Rank
NZ$50.02 B
Marketcap
NZ$228.75
Share price
-1.35%
Change (1 day)
23.43%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

ESG Reports

Thumbnail Celltrion
 ESG Report 2024-2025

ESG Report 2024-2025

Language: English

View ESG Report
Thumbnail Celltrion
 ESG Report 2023-2024

ESG Report 2023-2024

Language: English

View ESG Report
Thumbnail Celltrion
 ESG Report 2022-2023

ESG Report 2022-2023

Language: English

View ESG Report